Targeting the LINC01234/miR-124-3p/GRB2 axis reportedly increased the expression of miR-124-3p and inhibited the expression of the GRB2 protein through the downregulation of LINC01234, which ultimately decreased the proliferation of the MM tumor cells [57]. The gene discussed is LINC01234; the disease is Miyoshi myopathy.